drugset / Trial / NCT05253417
The CANabidiol Use for RElief of Short Term Insomnia
RandomizedParallel-groupDouble-blindTreatment
Summary
This study aims to investigate the effect of 50 mg and 100 mg per day oral CBD product versus a placebo over 8 weeks on insomnia severity in adults aged 18-65 years old with insomnia symptoms.
Timeline
- Start
- 2022-05-01
- Primary completion
- 2023-07-07
- Completion
- 2023-07-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 50 mg | Oral |
| Subject | Cannabidiol | Other / unclassified | 100 mg | Oral |